IXICO plc Result of AGM (5727C)

TIDMIXI

RNS Number : 5727C

IXICO plc

22 January 2018

22 January 2018

IXICO plc

("IXICO" or the "Company")

Results of AGM

IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.

For further information please contact:

 
 IXICO plc 
  Giulio Cerroni, Chief Executive            Tel: +44 20 
  Officer                                    3763 7499 
  Susan Lowther, Chief Financial Officer 
 
 Shore Capital (Nomad and Broker)          Tel: +44 20 
  Edward Mansfield/Anita Ghanekar           7408 4090 
 
 FTI Consulting Limited (Investor          Tel: +44 20 
  Relations)                                3727 1000 
  Simon Conway/Mo Noonan 
 

About IXICO

IXICO is the digital technologies company serving neuroscience. Our mission is to transform the pursuit of improving brain health through the application of digital technologies to neuroscience. IXICO's specialist data analytics services are used by the global pharmaceutical industry to select participants for clinical trials, assess the safety and efficacy of new drugs in development and in post marketing surveillance. Our neurological disease focus includes Alzheimer's disease, Huntington's disease, Multiple Sclerosis, Parkinson's disease and our integrated digital platform encompasses the entire drug development lifecycle. It is a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable sponsors to make rapid, better informed decisions. IXICO is also collaborating with partners to develop new companion digital health products targeted at improving patient outcomes.

More information is available on www.IXICO.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGFKBDDPBKDPDB

(END) Dow Jones Newswires

January 22, 2018 10:16 ET (15:16 GMT)